Research Study: ARTIST
Condition:
Heart Valve Disease, Aortic Regurgitation
Study Sponsor:
JenaValve Technology
Study Investigator:
Dr. Mario Goessl
Study Contact:
Every research study comes with its own unique risks and benefits; the study team will assess whether you’re an eligible candidate and ensure you’re provided with all the information you need to decide if participating is right for you.
About this Study:
To demonstrate non-inferiority of the Trilogy Transcatheter Heart Valve (THV) System compared with surgical aortic valve replacement (SAVR) for treatment of subjects with clinically significant native aortic regurgitation (AR).
